VA research: a new way to deliver autoimmune treatment, and virtual pain care for rural women veterans
Oct. 2, 2026 — VA researchers in Baltimore developed a microparticle that releases the anti-inflammatory compound itaconate inside cells and reduced inflammation-driving proteins in a mouse model of multiple sclerosis, the VA said. A separate eight-week virtual pain program for 31 rural women veterans was found beneficial by nearly all participants.
The wall: Results come from a mouse study and a 31-person pilot; neither is a treatment approval.
Tier: Confirmed (full text of VA research release)
Sources
This newsfeed was produced and brought to you by Temporal Data Dynamics Technology. For more information, visit temporaldatadynamics.com.